Aetherium Acquisition Corp. (GMFI) Signs LOI with Capital A
by Marlena Haddad on 2023-11-02 at 8:25am

Aetherium Acquisition Corp. (NASDAQ:GMFI) announced this morning that it has signed a non-binding letter of intent (LOI) to combine with some divisions of Capital A Berhad, the investment holding company of AirAsia.

Valued at $1 billion, the proposed business combination would result in new subsidiary Capital A International becoming a standalone publicly traded company. Capital A International intends to be an investment company that leverages the “AirAsia” brand and capitalizes on capabilities in aviation, travel and hospitality and digital technologies.

By owning 100% equity in AirAsia Brand and Leasing, Capital A International’s primary revenue sources will be from brand royalties and aircraft leasing. Furthermore, the company will actively engage in strategic acquisitions, business incubation, and partnerships to offer entrepreneurial platforms.

Under the terms of the LOI, Capital A intends to divest all issued and outstanding share capital of Capital A International.

Further details will be disclosed upon the signing of a definitive agreement in the weeks to come.

Aetherium currently has approximately $31 million in its trust account after seeing 73.99% redeemed during previous meetings. It initially raised $116.7 million from its IPO in December 2021 and set out to combine with businesses in the education, training, and education technology industries, specifically in Asia (excluding China). The SPAC is led by Chairman and Co-CEO Jonathan Chan, CFO Alex Lee and Co-CEO David Kopp.

Since there is no guarantee that this LOI will make it to the definitive agreement stage, Aetherium will stay in SPACInsider’s searching column for now.

Recent Posts
by Nicholas Alan Clayton on 2024-10-24 at 11:54am

DT Cloud (NASDAQ:DYCQ) has entered into a definitive agreement to combine with Maius Pharmaceutical at an equity value of $250 million. Shanghai-based Maius is a drug developer and researcher focused on small-molecule chemical treatments for different forms of cancer. The combined company is expected to trade on the Nasdaq once the deal is completed in...

by Nicholas Alan Clayton on 2024-10-24 at 10:18am

Charlton Aria Acquisition Corporation announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CHARU”, Thursday, October 24, 2024. The new SPAC plans to focus on industries that complement the management team’s and board of director’s background and network. The sponsor team for...

by Nicholas Alan Clayton on 2024-10-24 at 8:30am

At the SPAC of Dawn As the market goes through a cooling period this week, new readouts for jobless claims and new home sales are set to hit later today. Jobless claims are of course something of a proxy indicator for SPACs as to when the Fed might continue to its rate-cutting process, while home...

by Nicholas Alan Clayton on 2024-10-23 at 8:56pm

Bold Eagle Acquisition Corp. announced the pricing of its $250 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “BEAGU”, Thursday, October 24, 2024. The new SPAC plans to search for a combination target valued at $3 billion or more that would benefit from the relationships and experience...

by Nicholas Alan Clayton on 2024-10-23 at 8:54pm

Oaktree Acquisition Corp. III Life Sciences announced the pricing of its $175 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “OACCU”, Thursday, October 24, 2024. The new SPAC plans to combine with a healthcare target or one in a healthcare-related industry in North America or Europe. The...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved